InnovAge Quarterly Income Statement
NASDAQ: INNVHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
InnovAge revenue and earnings
In the quarter ended Jun 30, 2026, InnovAge generated $262.0 million in revenue, up 18.3% from the same quarter a year earlier. Net income was $8.3 million, for a net margin of 3.2% versus a median of -0.4% in the prior 5 quarters. Gross margin was 23.9% (up from 18.6%) and operating margin 3.9%.
Diluted earnings per share came in at $0.06.
Summary generated from market data by MetaCap's automated system. Methodology
InnovAge income statement (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 261.95M | 251.94M | 239.71M | 236.10M | 221.42M | 218.14M | 209.00M | 205.14M | 199.40M | 193.07M | 188.90M | 182.49M |
| Revenue growth (YoY) | +18.31% | +15.49% | +14.69% | +15.09% | +11.04% | +12.99% | +10.64% | +12.42% | +12.74% | +11.90% | +12.80% | +6.58% |
| Gross Profit | 62.56M | 61.02M | 52.83M | 51.36M | 41.29M | 40.75M | 37.06M | 34.54M | 36.58M | 34.00M | 33.61M | 27.88M |
| Operating Expenses | 52.42M | 90.10M | 39.56M | 43.07M | 43.44M | 50.91M | 49.62M | 39.44M | 41.46M | 39.79M | 35.40M | 38.59M |
| Selling, General & Admin | 43.01M | 85.28M | 34.69M | 37.88M | 34.92M | 45.52M | 35.81M | 34.03M | 36.13M | 34.73M | 31.11M | 34.33M |
| Operating Income | 10.15M | -29.08M | 13.26M | 8.29M | -2.15M | -10.16M | -12.56M | -4.90M | -4.88M | -5.79M | -1.78M | -10.72M |
| Interest Expense | — | — | — | — | — | — | — | — | — | 1.02M | 935.00K | 661.00K |
| Other Income (Expense) | -479.00K | -694.00K | -806.00K | -373.00K | -2.05M | -903.00K | -901.00K | -410.00K | 3.94M | -615.00K | -1.94M | -18.00K |
| Income Tax | -116.00K | 167.00K | 651.00K | 247.00K | 807.00K | 72.00K | 34.00K | 404.00K | 1.31M | -224.00K | 93.00K | 226.00K |
| Net Income | 8.29M | -29.46M | 10.62M | 8.02M | -785.00K | -11.38M | -13.22M | -4.93M | -1.70M | -5.89M | -3.45M | -10.30M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | 0.06 | -0.22 | 0.08 | 0.06 | 0.00 | -0.08 | -0.10 | -0.04 | -0.01 | -0.04 | -0.03 | -0.08 |
| EPS (Diluted) | 0.06 | -0.22 | 0.08 | 0.06 | 0.00 | -0.08 | -0.10 | -0.04 | -0.01 | -0.04 | -0.03 | -0.08 |
| Shares Outstanding (Basic) | — | 135.70M | 135.69M | 135.59M | — | 135.20M | 135.44M | 135.77M | — | 135.91M | 135.89M | 135.79M |
| Shares Outstanding (Diluted) | — | 135.70M | 136.35M | 136.76M | — | 135.20M | 135.44M | 135.77M | — | 135.91M | 135.89M | 135.79M |
| EBITDA | 16.50M | -24.25M | 18.14M | 13.37M | 1.24M | -4.77M | -7.24M | 514.00K | 446.00K | -731.00K | 2.50M | -6.45M |
| Gross Margin | 23.88% | 24.22% | 22.04% | 21.75% | 18.65% | 18.68% | 17.73% | 16.84% | 18.34% | 17.61% | 17.79% | 15.28% |
| Operating Margin | 3.87% | -11.54% | 5.53% | 3.51% | -97.00% | -4.66% | -6.01% | -2.39% | -2.45% | -3.00% | -94.00% | -5.87% |
| Net Margin | 3.16% | -11.69% | 4.43% | 3.40% | -35.00% | -5.22% | -6.33% | -2.40% | -85.00% | -3.05% | -1.82% | -5.65% |
This table shows 12 quarterly periods of InnovAge's income statement, from Q4 2026 back to Q1 2024, across 17 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow INNV's reporting calendar. What is a income statement?